6/26/2025

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Source: Yahoo

6/25/2025

Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today published its 2024 Corporate Responsibility Report.

Source: Yahoo

6/23/2025

2024 Corporate Responsibility Report Care starts here. ...

Source: Finnhub

6/23/2025

Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that it will report second quarter 2025 financial results on Tuesday, July 22, 2025, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.

Source: Yahoo

6/23/2025

While Quest Diagnostics has outshined the broader Nasdaq Composite over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

Source: Yahoo

6/20/2025

Quest Diagnostics stock is hovering in and around a buy zone. To limit risk, consider using a long call butterfly setup in options.

Source: Yahoo

6/18/2025

PreciseDx, the leading innovator behind PreciseBreast, a novel breast cancer diagnostic that is powered by OncoIntelligence, their proprietary AI-platform, today announced the successful closing of $11 million in funding and two key leadership hires. This latest round of funding was led by Eventide Asset Management ("Eventide"), Merck Global Health Innovation Fund and Philips Ventures and included Labcorp, Quest Diagnostics, GenHenn Capital Venture, along with other existing investors. This fund

Source: Yahoo

6/17/2025

Quest Diagnostics Inc. stock underperforms Tuesday when compared to competitors

Source: MarketWatch

6/17/2025

DGX stock rises on a new partnership with MD Anderson to develop a blood test targeting multiple cancer risks.

Source: Yahoo

6/17/2025

Quest Diagnostics delivered a strong start to the year, with revenue and adjusted profit both coming in above Wall Street expectations. Management attributed the robust performance to higher sales volumes, contributions from recent acquisitions, and expanded partnerships with large enterprise accounts. CEO Jim Davis pointed to particularly strong demand in advanced diagnostics, new health plan contracts, and the successful integration of acquired businesses as key factors supporting growth. Davi

Source: Yahoo

6/16/2025

Quest Diagnostics Inc. stock outperforms competitors on strong trading day

Source: MarketWatch

6/16/2025

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.

Source: Yahoo

6/13/2025

Quest plans to refine, develop and validate the technology and is aiming to launch the test in North America next year.

Source: Yahoo

6/12/2025

Quest Diagnostics Inc. stock underperforms Thursday when compared to competitors despite daily gains

Source: MarketWatch

6/10/2025

Quest Diagnostics announced a collaboration with The University of Texas MD Anderson Cancer Center designed to improve the assessment of elevated risk of cancer in individuals who would benefit from...

Source: Finnhub

6/10/2025

Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced a collaboration with The University of Texas MD Anderson Cancer Center (MD Anderson) designed to improve the assessment of elevated risk of cancer in individuals who would benefit from medically appropriate cancer screenings.

Source: Yahoo

6/4/2025

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.

Source: Yahoo

6/3/2025

Presenter SpeechUnknown Analyst All right. Hi, everyone. Good morning. Thanks again for joining us at this year's William Blair Growth Conference. This morning, we're very pleased to have the team...

Source: Finnhub

6/2/2025

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Source: Yahoo

6/2/2025

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the testing & diagnostics services industry, including Quest (NYSE:DGX) and its peers.

Source: Yahoo